Inoviem Scientific offers a range of services tailored to the needs of drug discovery, preclinical and clinical development.
Our expertise in translational pharmacology
Inoviem offers translational target discovery and drug-target Mode of Action (MoA) based on proprietary label-free technologies, developed in a pathological and physiological environment, that uses human tissue.
Inoviem provides breakthrough protein technologies for each phase of the drug development process.
One of the major advantages of our label-free technologies used under physiological conditions and in human tissue – NPOT® and PIMS® – is that the test compound retains its original structure, as well as the exact same molecular structure that would be used in therapy
- About us
Inoviem, a bioanalytical Contract Research Organization (CRO), enables drug developers to gain greater precision in the understanding of a compound’s clinical Mode of Action (MoA), so that a drug candidate can move rapidly to clinical trials.
Our approach is based on the simple idea that current technologies fail to take into account the natural environment in which a drug will have its beneficial effect…
Inoviem Scientific’s core values are deeply ingrained in our past, present and future; they guide us in our daily work…
- Contact us